Shares of DaVita reached record levels as the kidney care services company announced its significant expansion into Latin America through a $300 million acquisition. The stock soared to $136.10 during Tuesday morning trading, reflecting an impressive increase of nearly 30% this year.
Aggressive Growth Strategy
DaVita, headquartered in Denver, is making strategic moves following its agreement on four acquisitions from Fresenius Medical Care. The company’s international footprint will now extend to Brazil, Colombia, Chile, and Ecuador, with the Chilean deal already sealed.
Strengthening Presence in Latin America
With these transactions, DaVita is set to become a key player in the dialysis markets of South America. The combined entities are projected to employ over 15,000 staff members, delivering essential care to more than 60,000 patients across 270 clinics in the region.
Global Impact
By the end of 2023, DaVita was operating 3,042 dialysis outpatient centers worldwide, serving a patient base exceeding 250,000 individuals. The company’s visionary approach to expansion is poised to redefine the standards of kidney care on a global scale.